These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9314140)

  • 1. Systemic and regional hemodynamics in pre-ascitic cirrhosis.
    Bernardi M; Trevisani F
    J Hepatol; 1997 Sep; 27(3):588-91. PubMed ID: 9314140
    [No Abstract]   [Full Text] [Related]  

  • 2. [Simultaneous, study of systemic and regional visceral hemodynamics in cirrhosis. 3. Systemic and hepatosplanchnic hemodynamics in decompensated liver cirrhosis, with ascites].
    Greco F; Chiandussi L; Sardi G; Vaccarino A; Curti B; Agostoni A; Zardini P; Toscano G
    Minerva Med; 1967 Feb; 58(11):364-7. PubMed ID: 6019271
    [No Abstract]   [Full Text] [Related]  

  • 3. [Differential diagnosis and pathophysiologic principles of ascites].
    Paumgartner G; Gerbes AL
    Chirurg; 1993 Jan; 64(1):1-6. PubMed ID: 8382146
    [No Abstract]   [Full Text] [Related]  

  • 4. [Homeostatic mechanisms in decompensated cirrhosis. Ascites--status and perspectives].
    Henriksen JH
    Nord Med; 1984; 99(6-7):177-80. PubMed ID: 6473089
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pathogenesis of ascites formation in liver cirrhosis (author's transl)].
    Arbeiter G; Meyer-Burg J
    Leber Magen Darm; 1974 Oct; 4(6):299-307. PubMed ID: 4373632
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pathogenesis and therapy of ascites in liver cirrhosis].
    Janssens AR; van Brummelen P
    Ned Tijdschr Geneeskd; 1980 Jul; 124(28):1156-9. PubMed ID: 7402394
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal hemodynamics in patients with cirrhosis: relationship with ascites and liver failure.
    Moreau R; Gaudin C; Hadengue A; Braillon A; Roulot D; Bacq Y; Lebrec D
    Nephron; 1993; 65(3):359-63. PubMed ID: 8289984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective plasma oncotic pressure in hepatic cirrhosis and experimental ascites.
    Witte CL; Witte MH; Cole WR; Dumont AE
    Surg Forum; 1969; 20():378-80. PubMed ID: 5383090
    [No Abstract]   [Full Text] [Related]  

  • 9. [The ascitic syndrome in hepatic cirrhosis. (Clinical physiopathology)].
    Galea G
    Med Interna (Bucur); 1968 Apr; 20(4):389-96. PubMed ID: 5735411
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of anaprilin for the correction of portal hypertension in liver cirrhosis].
    Bondarenko IP; Dubinskiĭ AA; Tereshkin IG
    Vrach Delo; 1989 Nov; (11):19-22. PubMed ID: 2609578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperdynamic circulation of advanced cirrhosis: a re-appraisal based on posture-induced changes in hemodynamics.
    Bernardi M; Fornalè L; Di Marco C; Trevisani F; Baraldini M; Gasbarrini A; De Collibus C; Zacà F; Ligabue A; Colantoni A
    J Hepatol; 1995 Mar; 22(3):309-18. PubMed ID: 7608482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites.
    Wong F; Sniderman K; Liu P; Allidina Y; Sherman M; Blendis L
    Ann Intern Med; 1995 Jun; 122(11):816-22. PubMed ID: 7741365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma endothelin-1 and -3 in cirrhosis: relationship with systemic hemodynamics, renal function and neurohumoral systems.
    Bernardi M; Gulberg V; Colantoni A; Trevisani F; Gasbarrini A; Gerbes AL
    J Hepatol; 1996 Feb; 24(2):161-8. PubMed ID: 8907569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portal and systemic hemodynamics and humoral factors in cirrhosis with and without ascites.
    Hayes PC; Cumming AD; Craig KJ; Watson M; Bouchier IA
    Am J Gastroenterol; 1992 Oct; 87(10):1433-8. PubMed ID: 1415100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction.
    Nazar A; Guevara M; Sitges M; Terra C; Solà E; Guigou C; Arroyo V; Ginès P
    J Hepatol; 2013 Jan; 58(1):51-7. PubMed ID: 22989573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significances of plasma levels of neuropeptide Y pre- and post-treatment in patients with decompensated cirrhosis and ascites].
    Li GW; Wu LD; Zhu Y
    Di Yi Jun Yi Da Xue Xue Bao; 2003 May; 23(5):483-4. PubMed ID: 12754138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Negative influences of ascitic effusion on cardiac function in cirrhotics].
    Guazzi M; Polese A; Magrini F; Fiorentini C; Olivari MT
    Boll Soc Ital Cardiol; 1975; 20(10):1359-67. PubMed ID: 1234435
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathogenesis of ascites in cirrhosis and portal hypertension.
    Heneghan MA; Harrison PM
    Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting patterns of ascites formation in hepatic cirrhosis.
    Witte MH; Witte CL; Cole WR; Koehler PR
    JAMA; 1969 Jun; 208(9):1661-6. PubMed ID: 5818681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.